Search

Now showing items 31-40 of 41

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women

Manchanda, R; Patel, S; Gordeev, VS; Antoniou, AC; Smith, S; Lee, A; Hopper, JL; MacInnis, RJ; Turnbull, C; Ramus, SJ;... (2018-07)

Specifying the ovarian cancer risk threshold of "premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis

Manchanda, R; Legood, R; Antoniou, AC; Gordeev, VS; Menon, U (2016-09)

Cost-effectiveness of systematic population based screening for BRCA1, BRCA2, RAD51C, RAD51D and BRIP1 gene mutations in unselected general population women

Manchanda, R; Gordeev, V; Antoniou, A; Smith, S; Lee, A; Hopper, J; Macinnis, R; Paul, P; Simon, G; Susan, R;... (2016-10)

POPULATION-BASED TESTING FOR BRCA MUTATIONS (COMPARED TO FAMILY-HISTORY BASED TESTING) MAY BE COST SAVING IN ASHKENAZI-JEWS: A HEALTH-ECONOMICS DECISION ANALYTICAL MODEL

Manchanda, R; Legood, R; Burnell, M; McGuire, A; Loggenberg, K; Wardle, J; Sanderson, S; Gessler, S; Side, L; Balogun, N;... (2014-11)

ATTITUDE TOWARDS AND FACTORS AFFECTING UPTAKE OF POPULATION BASED BRCA TESTING IN ASHKENAZI JEWS: A COHORT STUDY

Manchanda, R; Burnell, M; Gaba, F; Sanderson, S; Loggenberg, K; Gessler, S; Wardle, J; Side, L; Desai, R; Brady, A;... (2019-09)

A NON-INFERIORITY CLUSTER RANDOMISED TRIAL COMPARING TRADITIONAL FACE-TO-FACE AND DVD-BASED GENETIC COUNSELLING IN SYSTEMATIC POPULATION BASED BRCA1/2 TESTING

Manchanda, R; Loggenberg, K; Burnell, M; Wardle, J; Sanderson, S; Gessler, S; Side, L; Balogun, N; Desai, R; Kumar, A;... (2015-10)

Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC-UK gynaecological oncology surgical outcomes and complications)

Iyer, R; Gentry-Maharaj, A; Nordin, A; Burnell, M; Liston, R; Manchanda, R; Das, N; Desai, R; Gornall, R; Beardmore-Gray, A;... (2015-02-03)

Setting the Threshold for Surgical Prevention in Women at Increased Risk of Ovarian Cancer.

Manchanda, R; Menon, U (2018-01)

The number of ovarian cancer cases is predicted to rise by 14% in Europe and 55% worldwide over the next 2 decades. The current absence of a screening program, rising drug/treatment costs, and only marginal improvements ...

Risk-reducing early salpingectomy and delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in women at increased risk: a commentary.

Gaba, F; Piek, J; Menon, U; Manchanda, R (2019-06)

Screening of symptomatic women for ovarian cancer.

Gentry-Maharaj, A; Kalsi, J; Burnell, M; Manchanda, R; Menon, U (2012-04)